Mimedx (MDXG) Shares Outstanding (Weighted Average) (2010 - 2026)

Mimedx's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $148.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 0.8% year-over-year to $148.4 million; the TTM figure through Mar 2026 stood at $148.4 million (up 0.8% YoY), while the FY2025 annual figure was $147.8 million, up 0.55% from the prior year.
• Shares Outstanding (Weighted Average) came in at $148.4 million for Q1 2026 at Mimedx, roughly flat from $147.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $148.4 million in Q1 2026 to a low of $111.6 million in Q1 2022.
• A 5-year average of $131.7 million and a median of $146.4 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) gained 27.98% in 2024 and grew 0.49% in 2025, its largest moves.
• Mimedx's Shares Outstanding (Weighted Average) stood at $112.9 million in 2022, then grew by 3.18% to $116.5 million in 2023, then increased by 26.17% to $147.0 million in 2024, then increased by 0.55% to $147.8 million in 2025, then gained by 0.44% to $148.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $148.4 million, $147.8 million, and $148.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison